Sabra Health Care REIT, Inc. (SBRA) Stock forecasts
Argus has lowered its target price for Sabra Health Care REIT Inc. (SBRA) to $21.00, with the current price at $20.15. The company operates as a healthcare facility real estate investment trust, focusing on owning and investing in healthcare real estate. This report from August 12, 2026, provides an updated outlook for the stock.
How Investors May Respond To Sabra Health Care REIT (SBRA) Profit Reversal And Steady Dividend
Sabra Health Care REIT (SBRA) recently reported a swing to a net loss of US$25.2 million in Q2 2026 despite increased revenue, while maintaining its quarterly dividend of US$0.30 per share. This situation raises questions about dividend coverage and financial flexibility, especially given the company's reliance on high dividend payouts amidst weaker profitability. Investors are encouraged to consider the implications of this mixed financial performance on the company's long-term investment narrative, particularly regarding its ability to sustain cash flows from senior housing and skilled nursing demand.
Quantinno Capital Management LP Grows Position in Sabra Healthcare REIT, Inc. $SBRA
Quantinno Capital Management LP significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 424.3% in the first quarter, bringing its total to 155,086 shares worth $2.98 million. Institutional investors now collectively own 99.4% of SBRA's outstanding stock. Despite missing EPS estimates, Sabra reported a 24.7% year-over-year revenue increase and declared a quarterly dividend of $0.30, representing a 5.7% annualized yield.
California State Teachers Retirement System Grows Position in Sabra Healthcare REIT, Inc. $SBRA
The California State Teachers Retirement System increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 32.2% in the first quarter, now owning 298,653 shares valued at $5.74 million. Institutional investors hold 99.4% of the stock. Analysts have a "Moderate Buy" consensus rating with an average price target of $22.25, despite the company missing earnings expectations in its last quarterly report.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Moderate Buy" from Brokerages
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received a "Moderate Buy" consensus rating from 14 analysts, with an equal split of seven buy and seven hold ratings, and an average 12-month price target of $22.25. The company reported better-than-expected revenue of $230.11 million, a 24.7% year-over-year increase, but missed EPS estimates with a loss of $0.10. Sabra also declared a quarterly dividend of $0.30 per share, resulting in a 5.7% yield, and institutional investors hold approximately 99.4% of its stock.
Raymond James upgrades Sabra Healthcare stock on tenant transitions By Investing.com
Raymond James upgraded Sabra Healthcare REIT Inc. (NASDAQ:SBRA) stock to Market Perform from Underperform, citing successful tenant and operator transitions that offset a discounted loan payoff. The firm noted $21 million in recurring net operating income improvements and updated its fair value estimate to $23 per share. Sabra also reported mixed Q2 2026 results with a net loss but increased revenue and reaffirmed full-year guidance due to strong senior housing demand.
Sabra Health Care REIT, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SBRA) 2026-08-07
Sabra Health Care REIT, Inc. (SBRA) published its Q2 2026 earnings call presentation on August 7, 2026. The company reported an EPS of $0.15, missing estimates by $0.02, while revenue of $235.87 million beat estimates by $16.41 million, representing a 24.70% year-over-year increase. This presentation was released in conjunction with their earnings call.
Raymond James upgrades Sabra Healthcare stock on tenant transitions
Raymond James upgraded Sabra Healthcare REIT Inc. (NASDAQ:SBRA) stock from Underperform to Market Perform, citing the positive impact of preannounced tenant and operator transitions which offset a discounted loan payoff. The firm noted $21 million in recurring net operating income improvements from de-risking the behavioral health segment. Raymond James set a fair value estimate of $23 per share, highlighting Sabra's compelling 5.69% dividend yield and 16 years of consistent dividend payments.
Earnings call transcript: Sabra Health Care REIT misses Q2 2026 EPS, beats revenue
Sabra Health Care REIT reported missing its Q2 2026 EPS estimate but surpassed revenue expectations, reaffirming its upgraded full-year outlook. The company's portfolio is benefiting from stronger senior housing performance and strategic transitions, despite a wider-than-expected loss due to a large loan-loss provision. Management remains optimistic about sustained growth driven by senior housing demand and ongoing investment activity.
Sabra Health Care REIT, Inc. Q2 2026 Earnings Call Summary
Sabra Health Care REIT (SBRA) reported strong Q2 2026 performance, driven by growth in its managed senior housing portfolio and increased rent coverage in skilled nursing. The company reaffirmed its 2026 earnings guidance, anticipating low to mid-teens growth in same-store SHOP NOI, and highlighted strategic initiatives including potential divestment from the behavioral segment and significant balance sheet flexibility. Management also addressed non-recurring items like a loan loss provision and discussed the rationale behind value-add acquisitions and sustainable RevPOR growth.
Sabra Health Care REIT Q2 Revenue Beats Estimates, AFFO Rises to $0.40
Sabra Health Care REIT reported strong Q2 2026 results with revenue of $235.866 million, exceeding analyst estimates, and Normalized AFFO increasing to $0.40 per share. This performance was driven by a 13.7% growth in same-property senior housing Cash NOI, despite a GAAP net loss due to significant loan loss provisions of $102.4 million. The company also declared a quarterly cash dividend of $0.30 per share and maintained approximately $1.3 billion in liquidity.
Sabra Health Care Reports Q2 2026 Earnings Results
Sabra Health Care reported a net loss of $0.10 per diluted share for Q2 2026, with FFO at negative $0.02 and normalized AFFO at $0.40. Despite the disappointing results, the company reaffirmed its full-year 2026 guidance, aiming to maintain investor confidence, though its shares fell by 2.65% following the report. Analyst views are mixed, with some raising price targets due to portfolio optimization efforts, while others maintain a neutral stance.
Sabra Healthcare earnings test: Can portfolio shift offset headwinds? By Investing.com
Sabra Healthcare REIT Inc. is set to report second-quarter earnings, with investors focused on whether its portfolio transformation can sustain momentum after shares reached a five-year high. Analysts anticipate modest sequential EPS growth but a year-over-year decline, with revenue expected to slip slightly. The company recently announced significant portfolio reshaping, including re-tenanting Avamere properties and exiting a $300 million mortgage, leading to raised full-year guidance and a 9% stock surge.
Sei Investments Co. Raises Stock Position in Sabra Healthcare REIT, Inc. $SBRA
Sei Investments Co. significantly increased its stake in Sabra Healthcare REIT, Inc. by 28.2% in the first quarter, now owning 544,221 shares valued at approximately $10.5 million. Other institutional investors also adjusted their positions, with hedge funds and institutional investors collectively owning 99.4% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for Sabra Healthcare REIT, with a consensus price target of $22.25, following strong quarterly results that met EPS expectations and exceeded revenue estimates.
Dimensional Fund Advisors LP Grows Holdings in Sabra Healthcare REIT, Inc. $SBRA
Dimensional Fund Advisors LP significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 7.8% in the first quarter of 2026, now holding 3.73 million shares valued at $71.6 million. Sabra Healthcare REIT reported strong first-quarter earnings, matching analyst EPS estimates and exceeding revenue expectations with a 20.9% year-over-year increase. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $22.25.
First Trust Advisors LP Raises Holdings in Sabra Healthcare REIT, Inc. $SBRA
First Trust Advisors LP significantly increased its stake in Sabra Healthcare REIT, Inc. by 99.4% during the first quarter, now holding 750,633 shares valued at over $14.4 million. Other institutional investors also adjusted their positions, with notable increases from Principal Financial Group Inc., Lasalle Investment Management Securities LLC, Norges Bank, Sumitomo Mitsui Trust Group Inc., and Balyasny Asset Management L.P. The article also provides a financial overview of Sabra Healthcare REIT, including recent earnings, analyst ratings, and a consensus target price of $22.25, indicating a "Moderate Buy" rating.
Sabra Health Care REIT, Inc. (SBRA) Stock Forecasts
This article provides a stock forecast for Sabra Health Care REIT Inc. (SBRA) from Argus, dated July 29, 2026. Argus provides an earnings estimate and a current price of $22.05 for SBRA, which operates in the healthcare real estate sector. The company's full report and additional premium research features are available with an upgrade.
Healthcare of Ontario Pension Plan Trust Fund Has $11.29 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA
The Healthcare of Ontario Pension Plan Trust Fund significantly increased its stake in Sabra Healthcare REIT, Inc. by 45.5% in the first quarter, now holding 587,253 shares valued at approximately $11.29 million. Institutional investors and hedge funds collectively own 99.4% of SBRA. Sabra Healthcare REIT reported strong first-quarter revenue of $211.74 million, up 20.9% year-over-year, with earnings per share matching analyst expectations at $0.16.
Public Employees Retirement System of Ohio Has $5.53 Million Position in Sabra Healthcare REIT, Inc. $SBRA
Public Employees Retirement System of Ohio significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 234.4% in the first quarter, now holding 287,522 shares valued at $5.53 million. This move reflects a broader trend of institutional investors adjusting their positions in the healthcare REIT. Analysts currently rate Sabra Healthcare REIT as a "Moderate Buy" with an average price target of $22.25.
Rush Island Management LP Purchases Shares of 1,598,287 Sabra Healthcare REIT, Inc. $SBRA
Rush Island Management LP has acquired 1,598,287 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), a stake valued at approximately $30.7 million, making it their 15th largest holding. Institutional ownership of Sabra Healthcare REIT remains high at 99.4%, with several major investors increasing their positions. The company reported strong quarterly revenue growth of 20.9% year-over-year, meeting earnings expectations, and analysts maintain a "Moderate Buy" rating with an average price target of $22.25.
Sabra Healthcare REIT (SBRA) to Announce Quarterly Earnings on Monday
Sabra Healthcare REIT (NASDAQ: SBRA) is expected to announce its Q2 2026 earnings on Monday, August 3rd, after market close, with analysts projecting $0.1711 EPS and $219.3870 million in revenue. The company's previous quarter saw it meet earnings estimates at $0.16 per share, while revenue surpassed expectations with 20.9% year-over-year growth to $211.74 million. Sabra Healthcare REIT currently holds a "Moderate Buy" rating from analysts with an average price target of $22.25.
BROOKFIELD Corp ON Invests $9.71 Million in Sabra Healthcare REIT, Inc. $SBRA
BROOKFIELD Corp ON has acquired a significant new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), purchasing over 500,000 shares valued at approximately $9.71 million. This investment highlights institutional confidence, with analysts giving SBRA a "Moderate Buy" rating and a consensus price target of $22.25. The real estate investment trust reported strong quarterly revenue growth and offers an attractive annual dividend yield of 5.4%.
Entropy Technologies LP Purchases 93,021 Shares of Sabra Healthcare REIT, Inc. $SBRA
Entropy Technologies LP significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 299.6% in the first quarter, acquiring 93,021 additional shares. This institutional activity, which brought their total holdings to 124,068 shares valued at $2.386 million, is part of a broader trend of institutional investment in SBRA, with various firms like Vanguard Group and Principal Financial Group also adjusting their positions. Analyst ratings are mixed, with a consensus of "Moderate Buy" and an average price target of $22.25, while the company recently announced a quarterly dividend of $0.30 per share.
Militia Capital Management LLC Buys Shares of 46,000 Sabra Healthcare REIT, Inc. $SBRA
Militia Capital Management LLC has acquired 46,000 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), valued at approximately $885,000, initiating a new position in the company during the first quarter. This investment comes as Sabra Healthcare REIT reported Q1 EPS of $0.16 on $211.74 million in revenue, meeting analyst estimates, and declared a quarterly dividend of $0.30 per share. Analysts currently rate SBRA as a "Moderate Buy" with a consensus target price of $22.25.
126,500 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Mizuho Markets Americas LLC
Mizuho Markets Americas LLC recently purchased 126,500 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) valued at approximately $2.43 million, establishing a new position in the company. Other institutional investors also adjusted their holdings in the REIT. Despite mixed analyst ratings, the consensus remains a "Moderate Buy" with an average price target of $22.25.
Systematic Financial Management LP Sells 57,628 Shares of Sabra Healthcare REIT, Inc. $SBRA
Systematic Financial Management LP decreased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 2.6% in the first quarter, selling 57,628 shares and retaining 2,154,881 shares valued at $41.4 million. Despite this reduction, analyst sentiment remains a "Moderate Buy" with an average price target of $22.25. Sabra Healthcare REIT reported first-quarter EPS of $0.16, meeting estimates, with revenue up 20.9% year-over-year, and paid a quarterly dividend of $0.30, yielding 5.4%.
Sabra Health Care REIT scales tested technologies across portfolio
Sabra Health Care REIT is expanding the use of successful pilot-tested technologies across its portfolio, as detailed in its sixth annual sustainability report. This initiative, part of a sustainability roadmap launched in 2021, focuses on practical innovations to strengthen communities and the portfolio long-term. In 2025, Sabra advanced water conservation, deployed autonomous floor-cleaning robots, achieved efficiency gains with heat pump retrofits, and expanded vital-sign technology in assisted living communities.
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
Sabra Health Care REIT, Inc. has released its sixth annual Sustainability Report for fiscal year 2025, detailing its progress in integrating sustainability into its business strategy. The report highlights the company's efforts to scale successful pilot technologies into portfolio-wide initiatives, focusing on improving care delivery, creating healthier environments, and strengthening the long-term resilience of its portfolio. Key advancements include significant water conservation, deployment of autonomous cleaning robots, efficiency gains through inverter heat pump retrofits, expansion of vital-sign technology, and efforts to improve care platform interoperability.
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
Sabra Health Care REIT, Inc. has released its sixth annual Sustainability Report for fiscal year 2025, detailing progress in integrating sustainability into its business strategy. The report highlights scaling pilot technologies into portfolio-wide initiatives to improve care delivery, enhance operational efficiency, and create healthier environments for residents and staff. Key achievements include significant water conservation, deployment of autonomous cleaning robots, efficiency gains through inverter heat pump retrofits, and advancements in healthcare technology interoperability.
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
Sabra Health Care REIT, Inc. has released its sixth annual Sustainability Report for fiscal year 2025, detailing its progress in integrating sustainability into its business strategy. The report highlights successful initiatives such as water conservation through new technologies, deployment of autonomous cleaning robots, and efficiency gains from inverter heat pump retrofits. Additionally, Sabra advanced care technology interoperability and maintained a low employee turnover rate, reflecting its commitment to long-term value creation and improving quality of life for residents.
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
Sabra Health Care REIT, Inc. has released its sixth annual Sustainability Report for fiscal year 2025, detailing its progress in integrating sustainability into its business strategy. The report highlights the company's efforts to scale pilot technologies into portfolio-wide initiatives, enhance care delivery, and invest in resilient operations. These initiatives aim to improve the quality of life for residents, create healthier environments for staff, and bolster the long-term resilience of its portfolio.
Lasalle Investment Management Securities LLC Has $73.55 Million Position in Sabra Healthcare REIT, Inc. $SBRA
Lasalle Investment Management Securities LLC significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 8.2% in the first quarter, now holding 3.82 million shares valued at $73.5 million. This position constitutes 2.9% of Lasalle's portfolio and is its 14th largest holding. The REIT reported Q1 earnings in line with expectations and raised its FY 2026 EPS guidance, maintaining a positive outlook from Wall Street analysts and offering an annualized dividend yield of about 5.5%.
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $24.00
Truist Financial has raised its price target for Sabra Healthcare REIT (NASDAQ:SBRA) from $22.00 to $24.00, reiterating a "buy" rating and suggesting a potential upside of 9.16%. The company holds a "Moderate Buy" consensus rating among analysts with an average target price of $22.25, reflecting mixed but generally constructive views. SBRA recently reported Q1 earnings and revenue that met or slightly exceeded expectations and provided FY2026 EPS guidance of $1.550–$1.590.
How Investors Are Reacting To Sabra Health Care REIT (SBRA) Re-Tenanting Avamere Portfolio To Boost Cash NOI
Sabra Health Care REIT (SBRA) recently announced the re-tenanting of 26 Avamere-leased properties, primarily to Cascadia Healthcare subsidiaries, a move expected to increase annualized cash NOI by over US$9 million and lift its 2026 full-year guidance. This transition is projected to boost annualized cash rent by nearly 30%, highlighting the company's active portfolio management. Investors are now focused on the upcoming Q2 2026 earnings release for further details on how this re-tenanting will impact updated guidance and cash flow expectations, particularly given the stock's high payout ratio and inherent operator transition risks.
Citizens raises Sabra Healthcare stock price target on guidance boost
Citizens upgraded its price target for Sabra Healthcare REIT Inc. (NASDAQ:SBRA) from $23.00 to $25.00, maintaining a Market Outperform rating. This adjustment follows Sabra's updated business guidance, which included an increase in full-year 2026 expectations due to strategic transactions and increased annualized rent. The company's stock has responded positively, trading near its 52-week high, with significant returns over the past year.
Sabra Health Care REIT to re-tenant 26 SNFs leased to Avamere, increases full-year guidance
Sabra Health Care REIT is transitioning 26 skilled nursing facilities currently leased to Avamere to new operators by year-end, with 22 going to Cascadia Healthcare and four to an existing, unnamed tenant. This move follows Avamere's decision to exit the skilled nursing business and is expected to increase Sabra's annualized cash rent from these properties by almost 30%. Sabra also increased its full-year 2026 guidance, reflecting these transactions and strong year-to-date operational performance.
How Investors Are Reacting To Sabra Health Care REIT (SBRA) Re-Tenanting Avamere Portfolio To Boost Cash NOI
Sabra Health Care REIT's recent re-tenanting of 26 Avamere-leased properties, primarily to Cascadia Healthcare, is projected to increase annualized cash NOI by over US$9 million and boost annualized cash rent by nearly 30%. This move is expected to significantly improve the REIT's income profile and risk mix, with further details anticipated during the Q2 2026 earnings call. While the rent uplift is encouraging, investors are also considering execution risks associated with operator transitions.
Sabra Healthcare REIT stock hits 52-week high at 21.29 USD
Sabra Healthcare REIT Inc. (SBRA) reached a new 52-week high of $21.29, reflecting growing investor confidence and a 17.4% total return over the past year. The company maintains a 6% dividend yield with 16 consecutive years of payments and boasts a market cap of $5.35 billion, alongside a "GREAT" financial health score from InvestingPro. Recent positive developments include meeting Q1 2026 earnings expectations, exceeding revenue guidance, S&P Global's outlook revision to positive, and new analyst coverage, underscoring its strategic focus on senior housing.
Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call
Sabra Health Care REIT, Inc. announced that it will release its second quarter 2026 earnings after the close of market on Wednesday, August 5, 2026. The company will also host a conference call and webcast on Thursday, August 6, 2026, at 9:00 AM Pacific Time to discuss the results.
Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that it will release its second quarter 2026 earnings on August 3, 2026, after market close. A conference call and webcast to discuss these results will be held on August 4th at 10:00 a.m. Pacific Time. The company is a self-administered real estate investment trust focused on the healthcare industry in the U.S. and Canada.
Sabra Health Care REIT sets Q2FY26 earnings release date
Sabra Health Care REIT announced its Q2 2026 earnings release for August 3, 2026, with a conference call scheduled for August 4, 2026, at 10:00 a.m. Pacific Time. The company provided dial-in information and a webcast link for investors to access the financial results discussion. Sabra specializes in healthcare real estate investments across the US and Canada.
Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) is scheduled to release its second quarter 2026 earnings on August 3, 2026, after the close of trading. The company will also host a conference call and webcast on August 4th at 10:00 a.m. Pacific Time to discuss these results. Sabra Health Care REIT operates as a self-managed real estate investment trust focused on properties serving the healthcare industry in the U.S. and Canada.
Independent Financial Group LLC Takes $3.68 Million Position in Sabra Healthcare REIT, Inc. $SBRA
Independent Financial Group LLC has acquired a new position in Sabra Healthcare REIT, purchasing 191,222 shares valued at approximately $3.68 million in the first quarter. Institutional investors and hedge funds own a significant portion of Sabra Healthcare REIT's stock, with several firms increasing their stakes. Analyst sentiment for SBRA is currently a "Hold" with an average price target of $21.45, while the company maintains a 6.0% dividend yield.
Diversify Wealth Management LLC Makes New $1.72 Million Investment in Sabra Healthcare REIT, Inc. $SBRA
Diversify Wealth Management LLC has made a new investment of $1.72 million in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by acquiring 84,501 shares in the first quarter. Institutional ownership of SBRA is notably high at 99.40%, with other firms also adjusting their stakes. Analyst ratings are mixed, with an average "Hold" rating and a consensus price target of $21.45, while the company’s recent quarterly earnings matched EPS estimates and surpassed revenue forecasts.
Principal Financial Group Inc. Buys 98,770 Shares of Sabra Healthcare REIT, Inc. $SBRA
Principal Financial Group Inc. increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 98,770 shares in the first quarter, bringing its total holding to over 25 million shares valued at approximately $481.8 million. The company's first-quarter earnings matched analyst expectations, while revenue exceeded estimates and grew significantly year-over-year. Despite positive financial results and a strong dividend yield, analyst ratings for Sabra Healthcare REIT have been mixed, with a consensus "Hold" rating.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of "Hold" by Analysts
Sabra Healthcare REIT (NASDAQ:SBRA) has received an average "Hold" recommendation from twelve brokerages, with an average one-year price target of $21.45. Analyst actions have been mixed, including upgrades to "overweight" by Wells Fargo and Barclays, a downgrade to "neutral" by Citigroup, and an "underperform" rating from Raymond James. The company recently reported quarterly EPS of $0.16, matching estimates, and revenue of $211.74 million, exceeding expectations, and pays a quarterly dividend of $0.30 (6.1% annualized yield).
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Sabra Healthcare REIT, Inc. $SBRA
Sumitomo Mitsui Trust Group Inc. has increased its stake in Sabra Healthcare REIT, Inc. by 6.8% in the first quarter, now holding 3.21 million shares valued at approximately $61.7 million. Despite recent analyst downgrades leading to a consensus "Hold" rating and an average price target of $21.45, other institutional investors have also adjusted their positions in the healthcare REIT. Sabra Healthcare REIT reported quarterly EPS of $0.16, meeting estimates, with revenue up 20.9% year-over-year, and issued a quarterly dividend of $0.30 per share.
Truist upgrades Sabra Healthcare stock rating to buy, sets $22 target
Truist Securities has upgraded Sabra Healthcare REIT Inc. (NASDAQ:SBRA) from hold to buy, establishing a price target of $22.00. The upgrade is based on projections of 7.8% average annual normalized funds from operations growth, driven by strong same-store net operating income in senior housing and accretive acquisition activity. The firm also noted Sabra's discounted valuation compared to peers and a 6.0% dividend yield.
Sabra Health Care REIT (SBRA) Stock Analysis Report | Ratings, Financials & Performance
This report provides a comprehensive analysis of Sabra Health Care REIT (SBRA), covering its ratings, financials, and performance. It details the company's operational activities as a healthcare facility REIT, its financial health through income statements, balance sheets, and cash flow statements, and its past performance and future growth potential based on analyst ratings and dividend history. The stock analysis also includes Benzinga Edge rankings for growth, value, and momentum, comparing SBRA to its peers.
Barclays Initiates Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Announces Target Price $21
Barclays has initiated coverage on Sabra Health Care REIT Inc (SBRA.US) with a "Hold" rating. The firm has set a target price of $21 for the company's stock, indicating its current valuation and future expectations.
